Table 1—

Treatment-emergent adverse events

Placebo5-μg exenatide10-μg exenatide
n113110113
Nausea26 (23)40 (36)51 (45)
Diarrhea9 (8)13 (12)18 (16)
Upper respiratory tract infection12 (11)15 (14)11 (10)
Vomiting4 (4)12 (11)13 (12)
Dizziness7 (6)10 (9)5 (4)
Sinusitis6 (5)5 (5)7 (6)
Hypoglycemia6 (5)5 (5)6 (5)
Back pain3 (3)3 (3)7 (6)
  • Data are n (%). Adverse events had an overall incidence ≥5% in any treatment arm and a higher incidence in an exenatide arm for the intent-to-treat population.